Impact of fibrosis progression on clinical outcome in patients treated for post‐ transplant hepatitis C recurrence

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|11|2433-2441

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.11, 2015-11, pp. : 2433-2441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibrosis progression in patients treated for hepatitis C recurrence

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2624-2625

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to Fibrosis progression in patients treated for hepatitis C recurrence

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2625-2625

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib

By  

Oncology, Vol. 92, Iss. 6, 2017-03 ,pp. : 335-346

Karger

Access to resources Recommend Favorite

Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post‐transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

High post‐transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor‐based triple therapy

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 510-517

John Wiley & Sons Inc

Access to resources Recommend Favorite